News
The majority of patients with the most common advanced or metastatic cancers in the United States do not undergo ...
The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.
Research from the NIH’s National Cancer Institute, an agency beleaguered by funding cuts and censorship, finds that ...
Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...
An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...
Cairns residents can now have free lung cancer screenings for the first time in a new nationwide program aiming to detect the deadly disease earlier in people with no symptoms.
As the U.S. Environmental Protection Agency reconsiders the ban on asbestos, an Indiana man suffering from asbestosis ...
Cancer is costly for patients and the NHS—but it also has a significant impact on the U.K. economy, according to research led ...
AstraZeneca secures EU approval for Imfinzi in muscle-invasive bladder cancer, expanding its cancer treatment portfolio.
CHEST guideline updates support minimally invasive resection and targeted therapy to enhance survival in Stage I–II NSCLC.
Breaking down what patients should know about each FDA therapeutic approval from June 2025 across various oncology ...
Nomograms have a strong reputation as reliable predictive models that simplify statistical prediction models and guide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results